CHOLESTAGEL

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Ireland, Lithuania, Netherlands, Poland, Spain, UK.

Active ingredients

The drug CHOLESTAGEL contains one active pharmaceutical ingredient (API):

1
UNII P4SG24WI5Q - COLESEVELAM HYDROCHLORIDE
 

Colesevelam is a non-absorbed, lipid-lowering polymer that binds bile acids in the intestine, impeding their reabsorption.

 
Read more about Colesevelam

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 CHOLESTAGEL Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C10AC04 Colesevelam C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1200328, 1200339, 1200340, 1849608
ES Centro de información online de medicamentos de la AEMPS 03268004
FI Lääkealan turvallisuus- ja kehittämiskeskus 098804
GB Medicines & Healthcare Products Regulatory Agency 125564, 374333, 376244
IE Health Products Regulatory Authority 73107
LT Valstybinė vaistų kontrolės tarnyba 1028228, 1028229, 1028230, 1056540
NL Z-Index G-Standaard, PRK 84093
PL Rejestru Produktów Leczniczych 100261890

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.